Pathology of catheter-related complications: what we need to know and what should be discovered

被引:16
作者
Wang, Lihua [1 ,2 ]
Jia, Lan [1 ,2 ]
Jiang, Aili [1 ,2 ]
机构
[1] Tianjin Med Univ, Hosp 2, Dept Kidney Dis, Tianjin, Peoples R China
[2] Tianjin Med Univ, Hosp 2, Blood Purificat Ctr, Tianjin, Peoples R China
基金
中国国家自然科学基金;
关键词
Tunneled cuffed catheter; hemodialysis; pathology; complication; thrombosis; infection; central vein stenosis; CENTRAL VENOUS CATHETERS; CUFFED HEMODIALYSIS CATHETERS; VASCULAR ACCESS; JUGULAR-VEIN; DIALYSIS; THROMBOSIS; BLOOD; DYSFUNCTION; PREVENTION; MODEL;
D O I
10.1177/03000605221127890
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Despite the considerable efforts made to increase the prevalence of autogenous fistula in patients on hemodialysis, tunneled cuffed catheters are still an important access modality and used in a high percentage of the hemodialysis population. However, because of the conundrum posed by tunneled cuffed catheters, patients can develop a multitude of complications, including thrombosis, infections, formation of a fibrin sheath, and central vein stenosis, resulting in increased morbidity and mortality as well as placing a heavy burden on the healthcare system. However, with an increasing number of studies now focusing on how to manage these catheter-related complications, there has been less translational research on the pathology of these complications. This review of the most recent literature provides an update on the pathological aspects of catheter-related complications, highlighting what we need to know and what is yet to be discovered. The future research strategies and innovations needed to prevent these complications are also addressed.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] The Future of Exertional Respiratory Problems What Do We Know About the Total Airway Approach and What Do We Need to Know?
    Olin, J. Tod
    Hull, James H.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2018, 38 (02) : 333 - +
  • [42] Transmission of Ebola Viruses: What We Know and What We Do Not Know
    Osterholm, Michael T.
    Moore, Kristine A.
    Kelley, Nicholas S.
    Brosseau, Lisa M.
    Wong, Gary
    Murphy, Frederick A.
    Peters, Clarence J.
    LeDuc, James W.
    Russell, Phillip K.
    Van Herp, Michel
    Kapetshi, Jimmy
    Muyembe, Jean-Jacques T.
    Ilunga, Benoit Kebela
    Strong, James E.
    Grolla, Allen
    Wolz, Anja
    Kargbo, Brima
    Kargbo, David K.
    Formenty, Pierre
    Sanders, David Avram
    Kobinger, Gary P.
    MBIO, 2015, 6 (02):
  • [43] Gun Homicide Research: What We Know and Where We Need to Go
    Buggs, Shani
    Zeoli, April M.
    HOMICIDE STUDIES, 2022, 26 (01) : 11 - 26
  • [44] Hearing Loss and Cognition: What We Know and Where We Need to Go
    Powell, Danielle S.
    Oh, Esther S.
    Reed, Nicholas S.
    Lin, Frank R.
    Deal, Jennifer A.
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 13
  • [45] Fetal alcohol spectrum disorders (FASD) - What we know and what we should know - The knowledge of German health professionals and parents
    Landgraf, Mirjam N.
    Albers, Lucia
    Rahmsdorf, Birte
    Vill, Katharina
    Gerstl, Lucia
    Lippert, Michaela
    Heinen, Florian
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2018, 22 (03) : 507 - 515
  • [46] Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know
    Zelek, Wioleta M.
    Harrison, Richard A.
    IMMUNOBIOLOGY, 2023, 228 (03)
  • [47] Improving our forecasts for trachoma elimination: What else do we need to know?
    Pinsent, Amy
    Gambhir, Manoj
    PLOS NEGLECTED TROPICAL DISEASES, 2017, 11 (02):
  • [48] What Rheumatologists should Know About Haemostaseology
    Doerner, T.
    AKTUELLE RHEUMATOLOGIE, 2016, 41 (02) : 137 - 144
  • [49] Human Extraintestinal Sarcocystosis: What We Know, and What We don't Know
    Harris, V. C.
    van Vugt, M.
    Aronica, E.
    de Bree, G. J.
    Stijnis, C.
    Goorhuis, A.
    Grobusch, M. P.
    CURRENT INFECTIOUS DISEASE REPORTS, 2015, 17 (08)